Pricing Log in Create free account
Friday 6 November 2026 Export HALO’s income statement to Excel — free account

Halozyme Therapeutics, Inc.

HALO Healthcare Biotechnology

Halozyme Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 37.6% from fiscal 2024.

Revenue
+39.2%
EPS
+45.6%
Free cash flow
−58.6%
Total debt
+115.1%

Quarter to September 2026, against a year earlier

103.93 19.03 −15.48%
Market cap
$14.0B
P/E
29.5×
Fwd P/E
17.9×
Dividend yield
—
F-score
5/9
Altman Z
3.46
Beneish M
−2.59
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Halozyme Therapeutics, Inc. (HALO) P/S ratio

Alert me on P/S ratio

As of 5 November 2026, Halozyme Therapeutics, Inc. (HALO) trades at a P/S ratio of 7.8×. Over the past ten years it has ranged from 4.9× (April 2026) to 33.7× (June 2015); the current reading is higher than 32% of that period. That is below the Biotechnology industry median of 9.2× and above the Healthcare sector median of 3.5×.

P/S ratio, daily

Embed this chart

Annual newest first

Period P/S ratio Change
FY2025 5.8× (3.30%)
FY2024 6.0× 0.40%
FY2023 5.9× (47.95%)
FY2022 11.4× (10.41%)
FY2021 12.8× (41.32%)
FY2020 21.7× 66.50%
FY2019 13.1× (5.62%)
FY2018 13.8× 58.95%
FY2017 8.7× (0.13%)
FY2016 8.7× (46.40%)

Quarterly newest first

Period P/S ratio Change
Sep 2026 7.0× 26.34%
Jun 2026 5.5× 8.99%
Mar 2026 5.1× (12.35%)
Dec 2025 5.8× (16.51%)
43 more quarters

Against its own ten years

Low 4.9× High 33.7×
Ten-year median 10.6×
Current reading's percentile 35

P/S ratio against peers

Company P/S ratio
BMRN BioMarin Pharmaceutical Inc. compare 3.0×
JAZZ Jazz Pharmaceuticals PLC compare 3.1×
EXEL Exelixis, Inc. compare 6.8×
HALO Halozyme Therapeutics, Inc. 7.8×
TECH Bio-Techne Corp compare 9.3×
ASND Ascendis Pharma A/S compare 13.5×
BBIO BridgeBio Pharma, Inc. compare 15.5×
KYMR Kymera Therapeutics, Inc. compare 120×
SMMT Summit Therapeutics PLC compare 15,884×
Biotechnology industry median 9.2×
Healthcare sector median 3.5×
Market median 1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on HALO